Analytical Methodology Development

分析方法开发

基本信息

项目摘要

Plasma is often the preferred specimen type when the goal of laboratory is to reduce the turnaround time and clotting occurences of the analytical systems. Recently, a blood collection tube containing Li heparin as anticoagulant and inert gel material to separate the blood cells from plasma, was introduced for routine laboratory use (Becton Dickinson Vacutainer? Plus, # 7961).We evaluated this plasma separator tube (PST) with Hitachi 917 for direct sampling and storage effect on 27 commonly measured analytes. Blood was collected into PST and serum separator tubes (SST) (Becton Dickinson Vacutainer Plus #7983) from volunteers (n=30), and for additional studies, into Li heparin anticoagulated tubes (PT) (Becton Dickinson Vacutainer Plus #7886). All tubes were centrifuged at the routine setting for the SST processing (RCF=2190xg, 5 min) within 30 min of collection. Samples were analyzed in batch mode from the primary tubes with Hitachi 917 fresh, and after storage for 8 hours at room temperature (rt), and up to 5 days at 4 oC. Significance of the mean difference (mdiff) was based on the imprecision of the method. In comparison with fresh serum, fresh plasma collected in PST had significantly different (mdiff1=plasma-serum) concentration of K (mdiff1=-0.23 mmol/L), albumin (mdiff1=0.1 g/dL), total protein (mdiff1=0.13 g/dL) and activity of ALT (mdiff1=-7 U/L) and LD (mdiff1=25 U/L). None of the measured analytes were affected by the storage of samples in PST and SST for 8 hours at rt. The effect of extended storage at 4 oC (mdiff2=stored-fresh) on plasma analytes of PST specimens was ignificant for bicarbonate (-5 mmol/L), K (0.9 mmol/L), Pi (-0.5 mg/dL), glucose (-7 mg/dL) and LD (39 U/L). In comparison, storage of serum in SST affected only LD activity (-10 U/L). The LD activity for fresh PST plasma was comparable to that for fresh PT plasma (mean: 180 and 174 U/Lrespectively). The extended storage of plasma in PST and PT at 4 oC caused an increase in the activity of LD (PST: mdiff2=30 U/L , PT: mdiff2=24 U/L), indicating incomplete separation of platelets by the gel barrier in PST. However, the PST plasma LD isoenzymes were not affected by storage at 4 oC. In addition, the increase in the PST plasma LD activity was not related to the centrifugation time (5, 8, and 10 min), or to the plasma platelet count. However, we observed that all centrifuged PSTs had varying amounts of erythrocytes imbedded in the gel and/or on top of the gel. This strongly suggests that the observed changes in LD and K were due to incomplete separation of plasma from red blood cells. In conclusion, we found PST to be acceptable for blood collection of heparinized plasma when appropriate changes in reference intervals for ALT, LD, and K are implemented. Furthermore, most of the common analytes are stable for up to 8 hours at ambient room temperature. However, the gel barrier does not provide satisfactory separation of plasma and cells and, therefore, the extended storage of plasma in primary tubes at 4 oC is not advisable.
当实验室的目标是减少分析系统的周转时间和凝结的情况时,血浆通常是首选的样品类型。最近,引入了一个含有液肝素的血管,该管子是抗凝剂和惰性凝胶材料,以将血细胞与血浆分开,以供常规实验室使用(Becton Dickinson vacutainer?plus,#7961)。我们评估了该血浆分离器管(PST)与Hitachi 917的血浆分离器管(PST),以直接采样和储存分析和储存率分析27.27常见的效果。将血液从志愿者(n = 30)(n = 30)中收集到PST和血清分离器管(SST)(SST)(Becton Dickinson Vacutainer Plus#7983),以及其他研究中,进入LI肝素抗凝管(PT)(Becton Dickinson Vacinson Vacutainer Plus#7886)。在收集30分钟内,在SST处理的常规设置(RCF = 2190xG,5分钟)的常规设置下,将所有试管离心。从Hitachi 917 Fresh的主要试管中分析样品,并在室温(RT)储存8小时后,最多5天以4 oC为单位。平均差异(MDIFF)的重要性是基于该方法的不精确。 In comparison with fresh serum, fresh plasma collected in PST had significantly different (mdiff1=plasma-serum) concentration of K (mdiff1=-0.23 mmol/L), albumin (mdiff1=0.1 g/dL), total protein (mdiff1=0.13 g/dL) and activity of ALT (mdiff1=-7 U/L) and LD (mdiff1=25 u/l)。在RT时,未通过样品在PST和SST中的样品存储8小时都没有影响所有测量的分析物。对于碳酸氢盐(-5 mmol/l),K(0.9 mmol/L),PI(-0.5 mg/dl),Glucose(-7 mg/dl)和LD(-7 mg/dl)和LD(39 u/l),碳酸氢盐(-5 mmol/L),K(-5 mmol/l),k(0.9 mmol/l),k(-5 mmol/l)和pi(-7 mmol/l)和ld(39 u/l),在4 OC(mdiff2 =储存的Fresh)对PST标本的血浆分析物对PST标本的血浆分析物的影响。相比之下,SST中血清的存储仅影响LD活性(-10 U/L)。新鲜PST等离子体的LD活性与新鲜PT血浆相当(平均:180和174 U/Lesprectity)。 PST中血浆的扩展存储在4 OC中的延长导致LD活性增加(PST:MDIFF2 = 30 U/L,PT:MDIFT2 = 24 U/L),表明PST中的凝胶屏障将血小板分离不完全。但是,PST等离子体LD同工酶不受4 oC的存储影响。另外,PST血浆LD活性的增加与离心时间(5、8和10分钟)或血浆血小板计数无关。但是,我们观察到所有离心的PST的凝胶和/或凝胶顶部嵌入的红细胞含量不同。这强烈表明,LD和K的观察到的变化是由于血浆与红细胞的分离不完全。总之,我们发现当实施ALT,LD和K的参考间隔时,PST可以接受肝素化血浆的血液收集。此外,大多数常见分析物在环境室温下最多可容纳8小时。但是,凝胶屏障不能提供血浆和细胞的令人满意的分离,因此,不建议在4 OC下将血浆扩展在原代管中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

NADJA REHAK的其他基金

ANALYTICAL METHODOLOGY: DEVELOPMENT AND INTERPRETIVE APPLICATION
分析方法:发展和解释性应用
  • 批准号:
    6289453
    6289453
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Magnesium Metabolism in Humans and Biological Systems
人体和生物系统中的镁代谢
  • 批准号:
    6103668
    6103668
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Magnesium Metabolism In Humans And Biological Systems
人体和生物系统中的镁代谢
  • 批准号:
    7004407
    7004407
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Analytical Methodology: Development And Interpretive App
分析方法:开发和解释应用程序
  • 批准号:
    6675178
    6675178
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Magnesium Metabolism In Humans And Biological Systems
人体和生物系统中的镁代谢
  • 批准号:
    6825429
    6825429
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Magnesium Metabolism In Humans And Biological Systems
人体和生物系统中的镁代谢
  • 批准号:
    6675179
    6675179
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Magnesium and Calcium Metabolism In Humans And Biological Systems
人体和生物系统中镁和钙的代谢
  • 批准号:
    7593102
    7593102
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Analytical Methodology: Development and Interpretive Application
分析方法:发展和解释应用
  • 批准号:
    6431834
    6431834
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Magnesium Metabolism In Humans And Biological Systems
人体和生物系统中的镁代谢
  • 批准号:
    6543078
    6543078
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Analytical Methodology: Development And Interpretive App
分析方法:开发和解释应用程序
  • 批准号:
    7004402
    7004402
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:

相似国自然基金

基于矩阵方法的电价博弈分析与控制策略研究
  • 批准号:
    62303170
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
联合连续弛豫时间分布与物理阻抗模型的锂离子电池极化特性演变分析方法
  • 批准号:
    22309205
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
多源异构地理分析模型互操作机制与方法研究
  • 批准号:
    42301539
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
应用分子影像方法探究帕金森病模型鼠心脏自主神经损伤的时间窗及心脏神经受体表达的分析
  • 批准号:
    82360352
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
适用于高分辨原子像中氧八面体转动定量分析的深度卷积神经网络构造方法学研究
  • 批准号:
    52301021
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Novel risk stratification score for patients presenting with acute Cerebral Venous Sinus Thrombosis
急性脑静脉窦血栓形成患者的新风险分层评分
  • 批准号:
    10592974
    10592974
  • 财政年份:
    2023
  • 资助金额:
    --
    --
  • 项目类别:
Development of an RNA-based anticoagulant and antidote for precise on/off coagulation control during cardiovascular procedures
开发基于 RNA 的抗凝剂和解毒剂,用于心血管手术期间精确的开/关凝血控制
  • 批准号:
    10603072
    10603072
  • 财政年份:
    2023
  • 资助金额:
    --
    --
  • 项目类别:
Sequencing Glycosaminoglycans using Single Molecule Enzyme Conductance Fluctuations
使用单分子酶电导波动对糖胺聚糖进行测序
  • 批准号:
    10568069
    10568069
  • 财政年份:
    2023
  • 资助金额:
    --
    --
  • 项目类别:
Evaluation of multiple medication exposures concurrently using a novel algorithm
使用新算法同时评估多种药物暴露
  • 批准号:
    10460760
    10460760
  • 财政年份:
    2019
  • 资助金额:
    --
    --
  • 项目类别:
Evaluation of multiple medication exposures concurrently using a novel algorithm
使用新算法同时评估多种药物暴露
  • 批准号:
    10363669
    10363669
  • 财政年份:
    2019
  • 资助金额:
    --
    --
  • 项目类别: